Background
==========

In the budding yeast *Saccharomyces cerevisiae*, glucose stimulates its transport across the plasma membrane by inducing expression of several *HXT*\[[@B1]-[@B3]\]. Under glucose-limited conditions, the transcriptional repressor Rgt1 binds to the *HXT*promoters and recruits general corepressors Ssn6 and Tup1 \[[@B4]-[@B7]\]. Rgt1 does this in conjunction with its corepressor Mth1, which physically interacts with Rgt1 \[[@B8]-[@B10]\]. Therefore, it has been proposed that Rgt1 forms a repression complex with Mth1, Ssn6, and Tup1 on the *HXT*promoters, inhibiting transcription \[[@B6]\]. Glucose appears to prevent formation of this protein complex by causing degradation of Mth1, resulting in release of Rgt1 from *HXT*promoters, thereby inducing expression of *HXT*\[[@B6],[@B11]-[@B14]\].

The glucose signal that leads to degradation of Mth1 is generated by the plasma-membrane spanning glucose sensors Rgt2 and Snf3. Signal generation is a receptor-mediated process and does not require glucose metabolism. This idea is supported by evidence that dominant mutations exist in the glucose sensor genes that lock the sensor proteins in glucose-bound conformations, generating a constitutive signal \[[@B15],[@B16]\]. Indeed, Mth1 is constitutively degraded in cells expressing the active glucose sensor mutants \[[@B17]\]. Subsequent studies have shown that the plasma membrane-tethered casein kinases Yck1/2 phosphorylate Mth1, triggering its ubiquitination and subsequent degradation \[[@B18]\]. It has also been shown by yeast-two-hybrid assay that Mth1 interacts with the C-terminal tails of the glucose sensors, suggesting that Mth1 is recruited to the plasma membrane \[[@B19]-[@B21]\]. These observations have led to the current view of glucose-induced *HXT*expression. Upon glucose binding, the glucose sensors are converted from inactive to active forms through a conformational change, activating Yck1/2 in their vicinity. Mth1, recruited by the glucose sensors to the plasma membrane, is phosphorylated by Yck1/2 and, subsequently, ubiquitinated by SCF^Grr1^. Finally, the ubiquitinated Mth1 is targeted for degradation by the 26S proteasome \[[@B12]-[@B14],[@B17]\].

However, this hypothesis is mainly based on the following assumptions: (1) Mth1 is excluded from the nucleus upon glucose addition and recruited to the plasma membrane by any means, and (2) Yck1/2 are activated through a direct interaction with the glucose sensors. In this study, we specifically tested these assumptions and provide evidence that Yck1/2 do not directly couple to the glucose sensors during transmission of the glucose signal from the plasma membrane to the nucleus. A possible mechanism for how the glucose sensors and Yck1/2 collaborate to degrade Mth1 is discussed.

Results
=======

Subcellular localization of Mth1 is not regulated
-------------------------------------------------

We have previously reported that GFP-Mth1 is mainly nuclear in glucose-depleted medium and is rapidly degraded upon glucose addition \[[@B14]\]. To gain more insights into glucose-dependent degradation of Mth1, we first examined subcellular localization of GFP-Mth1 in cells grown under conditions where *HXT*expression is repressed (2% galactose) or induced (4% glucose) (Figure [1](#F1){ref-type="fig"}). Because glucose also regulates expression of *MTH1*\[[@B22]\], *GFP-MTH1*was expressed from the *MET25*promoter, which is not regulated by glucose, in a low copy centromeric plasmid \[[@B14]\]. Fluorescence microscopy analysis demonstrates that GFP-Mth1 is localized primarily to two specific foci within the nucleus and that \~50% of fluorescence is recovered within 30-40 seconds after photobleaching (Figure [1A](#F1){ref-type="fig"}). These results suggest that, under glucose-limited conditions, Mth1 predominantly accumulates in the nucleus but does not shuttle between the nucleus and cytoplasm. We also monitored glucose-induced degradation of Mth1 in a time-lapse manner and observed that more than half of GFP-Mth1 is degraded within 5-10 min after glucose addition (Figure [1B](#F1){ref-type="fig"}), which is consistent with the Western blot analysis obtained previously \[[@B14]\].

![**Mth1 does not shuttle between the nucleus and cytoplasm**. (A) Images of GFP-Mth1 expressing yeast cells grown in galactose (2%) before and after photobleaching in the indicated region. One of two foci (arrow) was bleached and then recovery of the fluorescence in the bleached zone was monitored. Time is in seconds after photobleaching. (B) Time-lapse observation of Mth1 degradation in high-glucose medium (4%). Numbers indicate time in minutes. Yeast cells, wild-type (*WT*; BY4742) and *grr1*mutant (*grr1Δ*; YM4783), expressing GFP-Mth1 were observed under the Zeiss LSM 510 META Confocal Laser Scanning Microscope (CLSM).](1471-2121-11-17-1){#F1}

To determine whether Mth1 is excluded from the nucleus in response to glucose, we determined in which cellular compartment Mth1 is localized when expressed under high glucose conditions. Toward this aim, we examined subcellular localization of GFP-Mth1 in the *rgt2snf3*and *grr1*mutants, where glucose-dependent degradation of Mth1 is severely impaired \[[@B14]\]. As shown in Figure [2A](#F2){ref-type="fig"}, the GFP-Mth1 proteins accumulate in the nucleus of the mutants grown in high-glucose medium. To further test a possibility that the glucose sensors regulate nuclear exclusion of Mth1, we determined subcellular localization of a nondegradable form of Mth1 in wild-type cells, where the glucose sensors are active. The dominant *HTR1-23*mutation in *MTH1*(I85S) \[[@B23]\] converts Mth1 into a degradation-resistant form \[[@B14]\]. Our results indicate that the mutant Mth1 proteins (GFP-Mth1-I85S) are not degraded, as expected, but accumulate in the nucleus in high-glucose medium (Figure [2B](#F2){ref-type="fig"}). We also observed that subcellular localization and degradation of Mth1 are not influenced by the absence of Rgt1, a downstream target of the Rgt2/Snf3-mediated signaling pathway \[[@B22]\]. Therefore, it is likely that neither glucose nor the glucose sensors control nuclear export of Mth1.

![**Neither glucose nor the glucose sensors influence the subcellular localization of Mth1**. (A) Yeast cells of the indicated genotype expressing GFP-Mth1 were grown to mid-log phase in a selective medium containing 2% galactose. Aliquots were then transferred to 2% galactose medium (Gal) or 4% glucose medium (Glu) and incubated for 60 min. Subcellular localization of GFP-Mth1 was analyzed by fluorescence microscopy. Yeast cells used were: *WT*(BY4742), *rgt2Δsnf3Δ*(YM6370), *grr1Δ*(YM4783), and *rgt1Δ*(YM4509). (B) Localization of a nondegradable form of Mth1 (Mth1-I85S) in wild-type cells (BY4742). (C) GFP-Rgt1 localization as a positive control.](1471-2121-11-17-2){#F2}

Glucose-dependent degradation of Mth1 occurs in the nucleus
-----------------------------------------------------------

To more directly assess whether Mth1 degradation occurs in the nucleus or cytoplasm, we examined degradation of GFP-Mth1 proteins engineered to have cytoplasmic localization. To do so, GFP-Mth1 was tagged with the nuclear export signal (NES) of the yeast PKIα (GFP-NES-Mth1) \[[@B24]\]. To test the functionality of the NES motif, we constructed plasmid expressing GFP-NES(m)-Mth1 containing a single amino acid substitution within the motif. The levels and subcellular localization of the resulting fusion proteins were determined by Western blot and fluorescence microscopy analysis, respectively (Figure [3](#F3){ref-type="fig"}). We observed that GFP-NES-Mth1 is excluded from the nucleus, as expected (Figure [3A](#F3){ref-type="fig"}, bottom panel), but significantly degraded regardless of the presence of glucose or the glucose sensors (Figure [3B](#F3){ref-type="fig"}). In contrast, GFP-Mth1 with a nonfunctional NES motif (GFP-NES(m)-Mth1) behaves like GFP-Mth1; it accumulates in the nucleus in the absence of glucose (2% Gal) but is degraded when glucose is present (4% Glu), providing evidence that the NES motif used is functional. Therefore, collectively, these results suggest that glucose-dependent degradation of Mth1 occurs in the nucleus.

![**Glucose-dependent degradation of Mth1 takes place in the nucleus**. Synthetic oligonucleotides encoding the nuclear export sequence (NES) and its mutant peptide (NES (m)) were inserted between the *GFP*and *MTH1*genes in the *GFP-MTH1*construct. Yeast cells (*mth1Δ*, YM6266) expressing GFP-Mth1 and its derivatives were grown as described in Figure 2. Subcellular localization and levels of GFP-Mth1 were analyzed by fluorescence microscopy using CLSM (A) and Western blotting using anti-GFP antibody (B), respectively.](1471-2121-11-17-3){#F3}

Nuclear degradation of Mth1 is Grr1-dependent
---------------------------------------------

Grr1 appears to be present in both the nucleus and cytoplasm, but deletion of the putative NLS in the amino-terminus of Grr1 (Grr1ΔN) causes it to be localized to the cytoplasm \[[@B25]\]. Previous studies have shown that expression of Grr1ΔN is sufficient to restore the morphology of, and to mediate degradation of Gic2 in, the *grr1*mutant \[[@B25],[@B26]\], suggesting that Grr1ΔN is fully functional in the cytoplasm. To provide more compelling evidence that Grr1-dependent degradation of Mth1 takes place in the nucleus, we examined if GFP-Grr1ΔN (Δ1 280) can mediate Mth1 degradation (Figure [4](#F4){ref-type="fig"}). Our results show that GFP-Grr1ΔN is predominantly localized to the cytoplasm (Figure [4A](#F4){ref-type="fig"}) and able to restore the morphology of the *grr1*mutant (Figure [4B](#F4){ref-type="fig"}), as reported previously \[[@B25],[@B26]\]. However, expression of Grr1ΔN in the *grr1*mutant does not cause degradation of GFP-Mth1 (Figure [4C](#F4){ref-type="fig"}), probably due to translocation of Grr1ΔN from the nucleus to the cytoplasm (Figure [4B](#F4){ref-type="fig"}). These results suggest that SCF^Grr1^-mediated degradation of Mth1 occurs in the nucleus, not in the cytoplasm.

![**Glucose-dependent degradation of Mth1 does not occur when Grr1 is removed from the nucleus**. (A) GFP-Grr1 and GFP-Grr1ΔN (lacking the first 280 amino acids of Grr1) were expressed in the *grr1Δ*mutant (YM4783) in high-glucose medium (4%). (B) GFP-Mth1 was expressed alone (top) or coexpressed with Grr1-ΔN (bottom) in the *grr1*mutant (YM4783). Subcellular localization of GFP-Mth1 and GFP-Grr1ΔN was analyzed by fluorescence microscopy (A and B). (C) GFP-Mth1 was expressed alone (top) or coexpressed with Grr1-ΔN (bottom) in the *grr1*mutant (YM4783), and levels of GFP-Mth1 were analyzed by Western blotting using anti-GFP antibody. Yeast cells were grown in 2% galactose medium (Gal) or 4% glucose medium (Glu) as described in Figure 2.](1471-2121-11-17-4){#F4}

Direct interaction between Yck1/2 and the glucose sensors is not required for glucose-dependent degradation of Mth1
-------------------------------------------------------------------------------------------------------------------

Next, we tested whether the glucose sensors are coupled with Yck1/2 in order to transduce glucose binding into an intracellular signaling cascade that leads to Mth1 degradation. Toward this aim, we examined whether Mth1 is degraded when Yck1/2 are mislocalized from the plasma membrane. It has been well described that Yck2 is targeted to the plasma membrane through palmitoylation of the C-terminal Cys-Cys sequence by the palmitoyl transferase Akr1 \[[@B27]-[@B29]\]. Confocal microscopy images show that, like GFP-Yck2 \[[@B29]\], GFP-Yck1 is associated with the plasma membrane in wild-type cells, but diffused throughout the entire cell when Akr1 is absent (Figure [5A](#F5){ref-type="fig"}, *akr1Δ*). Importantly, glucose-induced degradation of Mth1 is not significantly impaired in the absence of Akr1 (Figure [5B](#F5){ref-type="fig"}). These results suggest that neither localization of Yck1/2 to the plasma membrane nor a direct interaction between Yck1/2 and the glucose sensors is required for degradation of Mth1.

![**Direct interaction of Yck1/2 with the glucose sensors is not required for degradation of Mth1**. (A) Subcellular localization of GFP-Yck1 and GFP-Yck2 expressed in wild type (BY4742) and *akr1Δ*mutant (JKY56) strains was examined by fluorescence microscopy. (B) Western blot analysis of GFP-Mth1 in wild-type and *akr1Δ*mutant strains. Yeast cells were grown as described in Figure 2.](1471-2121-11-17-5){#F5}

Four different regions of Mth1 are required for glucose-induced degradation of Mth1
-----------------------------------------------------------------------------------

To identify the regions of Mth1 that are required for its glucose-induced degradation, we constructed a series of successive internal deletions of 10-50 residues covering the entire Mth1 sequence (Figure [6A](#F6){ref-type="fig"}). The amino acid positions between 20 and 80 of Mth1 were not deleted because this region is not well conserved in the Mth1 orthologs from other yeast species. Most of the deletion mutants of Mth1 protein were detectable by Western blotting, except two mutants that contain Δ235-262 (ID 11) and Δ298-319 (ID 13) (Figure [6B](#F6){ref-type="fig"}). Our results show that four internal deletions\--Δ81-90 (ID 2), Δ118-138 (ID 4), 156-180 (ID 6), and Δ326-343 (ID 15)\--render Mth1 resistant to degradation. These Mth1 mutant proteins are constitutively nuclear (data not shown) and significantly inhibit glucose induction of *HXT1*expression (Figure [6C](#F6){ref-type="fig"}). Proteasomal degradation of proteins is a multi-step process, involving phosphorylation, ubiquitination, and degradation in the 26S proteasome. Thus, it is likely that these four regions are involved in at least one of these steps.

![**Identification of the functional regions of Mth1 required for glucose-dependent degradation**. (A) Mth1 deletion mutants were generated to determine the regions responsible for degradation by successive 10-50 amino-acids deletion analysis. In total, 18 deletions were constructed. (B) The mutant Mth1 proteins containing internal deletions were expressed in the *mth1Δ*cells (YM6266) and detected by Western blotting using anti-GFP antibody. (C) Four deletion mutants of Mth1 inhibit glucose-induction of *HXT1*expression. Four internal deletion constructs without the GFP moiety were coexpressed with the *HXT1*-*lacZ*reporter (pBM2636) in the absence (Gal, black bars) and presence (Glu, gray bars) of glucose.](1471-2121-11-17-6){#F6}

Discussion
==========

The yeast glucose sensors convert glucose binding events into an intracellular signal that leads to degradation of Mth1, which is known to require activity of the plasma membrane-tethered Yck1/2 \[[@B18]\]. Because both the glucose sensors and Yck1/2 are associated with the plasma membrane, it has been hypothesized that, upon glucose addition, Yck1/2 are activated through a direct interaction with the glucose sensors and phosphorylate Mth1, triggering its proteasomal degradation.

In this study, we provide several lines of evidence that Mth1 does not shuttle between the nucleus and cytoplasm and is degraded in the nucleus when glucose is present: 1) Mth1 is not excluded from the nucleus in response to glucose (Figure [2](#F2){ref-type="fig"}); 2) When engineered to be localized to the cytoplasm, Mth1 is degraded in the cytoplasm regardless of the presence of glucose and the glucose sensors (Figure [3](#F3){ref-type="fig"}); 3) Mth1 is not degraded when Grr1 is removed from the nucleus (Figure [4](#F4){ref-type="fig"}).

The majority of Yck1/2 targets are plasma membrane proteins. Yck1/2 are responsible for phosphorylating the PEST-like ubiquitination-endocytosis signal of the mating pheromone receptors \[[@B30]\], and the uracil permease Fur4 \[[@B31]\]. These kinases are also known to regulate the activity of the maltose permease Mal61 \[[@B32]\], the multidrug transporter Pdr5 \[[@B33]\], and plasma membrane H^+^-ATPase \[[@B34]\]. Another important target of Yck1/2 is Ptr3, a component of the yeast amino-acid signaling pathway. Extracellular amino acids trigger activation of the Ssy1-Ptr3-Ssy5 (SPS)-amino acid signaling pathway that leads to induction of endoproteolytic processing of Stp1 and Stp2, enabling them to enter the nucleus and induce expression of the amino acid permease genes \[[@B35]-[@B38]\]. This processing requires Yck1/2, the novel chymotrypsin like protease Ssy5, and SCF^Grr1^\[[@B36],[@B37]\]. Yck1/2 have been shown to phosphorylate the peripheral plasma membrane protein Ptr3 at Thr-525, increasing Ssy5C (C-terminal activity domain)-dependent proteolytic processing of Stp1 and Stp2 \[[@B39]\]. Mth1 is required to form a repression complex with Rgt1 on the *HXT*promoters \[[@B6]\] and appears not to contain endogenous NES-like motifs in its sequence (data not shown). These observations support the idea that Mth1 neither shuttles between the nucleus and cytoplasm nor is excluded from the nucleus. Therefore, it is unlikely that the plasma membrane-tethered Yck1/2 directly phosphorylate the nuclear-localized Mth1.

We also provide evidence that Mth1 degradation is not impaired by the mislocalization of Yck1/2 from the plasma membrane, suggesting that direct interaction between the glucose sensors and Yck1/2 is not required for Mth1 degradation (Figure [5](#F5){ref-type="fig"}). Although Yck1/2 have been reported to be necessary for Mth1 degradation \[[@B18]\], our results suggest that they do not exert their function through the glucose sensors. It is not known how the glucose binding to the glucose sensors is converted to an intracellular signal that leads to degradation of Mth1. In this regard, we surmise that there is a yet unidentified kinase that receives the glucose signal and converts it into an intracellular signal. In this scenario, the kinase is recruited to the glucose sensors upon glucose addition and phosphorylated by Yck1/2 at the plasma membrane. Finally, the kinase is translocated from the cytoplasm into the nucleus and catalyzes phosphorylation of Mth1, triggering its degradation by the 26S proteasome.

Conclusions
===========

Glucose-induced, the glucose sensor-regulated Mth1 degradation occurs in the nucleus and requires neither nuclear export of Mth1 nor direct interaction between the glucose sensors and Yck1/2. The glucose sensors transmit their signal across the plasma membrane through a yet unidentified signaling component, not through Yck1/2.

Methods
=======

Yeast strains and plasmids
--------------------------

Yeast strains were grown on YPD (1% yeast extract, 2% bacto-peptone, and 4% glucose) or synthetic yeast nitrogen base media (0.17% yeast nitrogen base with 0.5% ammonium sulfate) supplemented with the appropriate amino acids and carbon sources. The *AKR1*gene was disrupted by homologous recombination using the NatMX cassette \[[@B40]\]. Plasmids that express the mutant Mth1 proteins with internal deletions were constructed by using the gap-repair technique \[[@B41]\]. To construct the *GFP-MTH1*tagged with either the wild-type (NES, ELALKLAGLDIN) or mutated (NESm, ELALKLAG[A]{.ul}DIN; L changed to A (Underlined)) leucine-rich nuclear export sequences of the yeast PKIα \[[@B42]\], synthetic oligonucleotides encoding the NES and NES(m) peptides were inserted between the *GFP*and *MTH1*genes in the *GFP-MTH1*construct \[[@B14]\]. Plasmids used in this study are listed in Table [1](#T1){ref-type="table"}.

###### 

Plasmids used in this study

  Plasmid               Description                                                            Source
  --------------------- ---------------------------------------------------------------------- ------------
  GFP-Mth1              Mth1-GFP fusion protein (pUG34 or pUG36)                               17
  GFP-NES-Mth1          Mth1-GFP fusion protein with NES                                       This study
  GFP-NES (m)-Mth1      Mth1-GFP fusion protein with NES (L changed to A)                      This study
  GFP-Grr1              Grr1-GFP fusion protein                                                This study
  GFP-Grr1ΔN            Grr1-GFP fusion protein without amino acids from 1 to 280 \[[@B26]\]   This study
  GFP-Yck1              Yck1-GFP fusion protein                                                This study
  GFP-Yck2              Yck2-GFP fusion protein                                                This study
  Mth1 ID 1             GFP-Mth1 fusion protein without amino acids from 1 to 20               This study
  Mth1 ID 2             GFP-Mth1 fusion protein without amino acids from 81 to 90              This study
  Mth1 ID 3             GFP-Mth1 fusion protein without amino acids from 88 to 119             This study
  Mth1 ID 4             GFP-Mth1 fusion protein without amino acids from 118 to 138            This study
  Mth1 ID 5             GFP-Mth1 fusion protein without amino acids from 137 to 157            This study
  Mth1 ID 6             GFP-Mth1 fusion protein without amino acids from 156 to 180            This study
  Mth1 ID 7             GFP-Mth1 fusion protein without amino acids from 179 to 188            This study
  Mth1 ID 8             GFP-Mth1 fusion protein without amino acids from 187 to 200            This study
  Mth1 ID 9             GFP-Mth1 fusion protein without amino acids from 198 to 214            This study
  Mth1 ID 10            GFP-Mth1 fusion protein without amino acids from 213 to 236            This study
  Mth1 ID 11            GFP-Mth1 fusion protein without amino acids from 235 to 262            This study
  Mth1 ID 12            GFP-Mth1 fusion protein without amino acids from 261 to 299            This study
  Mth1 ID 13            GFP-Mth1 fusion protein without amino acids from 298 to 319            This study
  Mth1 ID 14            GFP-Mth1 fusion protein without amino acids from 318 to 327            This study
  Mth1 ID 15            GFP-Mth1 fusion protein without amino acids from 326 to 343            This study
  Mth1 ID 16            GFP-Mth1 fusion protein without amino acids from 342 to 363            This study
  Mth1 ID 17            GFP-Mth1 fusion protein without amino acids from 363 to 380            This study
  Mth1 ID 18            GFP-Mth1 fusion protein without amino acids from 390 to 433            This study
  Mth1 ID 2 tag-less    Mth1 without amino acids from 81 to 90                                 This study
  Mth1 ID 4 tag-less    Mth1 without amino acids from 118 to 138                               This study
  Mth1 ID 6 tag-less    Mth1 without amino acids from 156 to 180                               This study
  Mth1 ID 15 tag-less   Mth1 without amino acids from 326 to 343                               This study

Fluorescence microscopy and FRAP (Fluorescence Recovery After Photobleaching)
-----------------------------------------------------------------------------

GFP-fusion proteins expressed in yeast cells were visualized using a Zeiss LSM 510 META confocal laser scanning microscope with a 63× Plan-Apochromat 1.4 NA Oil DIC objective lens (Zeiss) \[[@B17]\]. All images documenting GFP localization were acquired with the Zeiss LSM 510 software version 3.2. For FRAP of GFP-Mth1, one of the foci was bleached with a laser pulse and the subsequent recovery of fluorescence was monitored \[[@B17]\].

Western blotting
----------------

Western blotting was performed as described previously \[[@B6]\]. Briefly, 5 ml of yeast cells (O.D~600~= 1.2) were collected by centrifugation at 3,000 rpm in a table-top centrifuge for 5 min. The cell pellets were resuspended in 100 μl of SDS-buffer (50 mM Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, 5% β-mercaptoethanol) and boiled for 5 min. After the lysates were cleared by centrifugation at 12,000 rpm for 10 min., soluble proteins were resolved by SDS-PAGE and transferred to PVDF membrane (Millipore). The membranes were incubated with appropriate antibodies in TBST buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Tween-20) and proteins were detected by the enhanced chemiluminescence (ECL) system (Pierce).

β-galactosidase assay
---------------------

To assay β-galactosidase activity with yeast cells expressing appropriate *lacZ*reporters, yeast cells were grown to mid-log phase and assay was performed as described previously \[[@B6]\]. Results were reported in Miller Units \[(1,000 × OD~420~)/(*T*× *V*× OD~600~), where OD~420~was the optical density at 420 nm, *T*was the incubation time in minutes, and *V*is the volume of cells in milliliters\]. The reported enzyme activities were averages of results from triplicates of three different transformants.
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